Global Tuberculosis Screening Market Growth (Status and Outlook) 2023-2029

Global Tuberculosis Screening Market Growth (Status and Outlook) 2023-2029

The global Tuberculosis Screening market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Tuberculosis Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Tuberculosis Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Tuberculosis Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Tuberculosis Screening players cover Qiagen, Sanofi, Oxford Immunotec, BioMerieux, Par Sterile, Bio-Rad Laboratories, Akonni Biosystems, Becton Dickinson and Abbott, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “Tuberculosis Screening Industry Forecast” looks at past sales and reviews total world Tuberculosis Screening sales in 2022, providing a comprehensive analysis by region and market sector of projected Tuberculosis Screening sales for 2023 through 2029. With Tuberculosis Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis Screening industry.

This Insight Report provides a comprehensive analysis of the global Tuberculosis Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tuberculosis Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tuberculosis Screening market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis Screening and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis Screening.

This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis Screening market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Active Tuberculosis
Latent Tuberculosis

Segmentation by application
Hospital
Clinic
Diagnostic Center
Laboratories
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Qiagen
Sanofi
Oxford Immunotec
BioMerieux
Par Sterile
Bio-Rad Laboratories
Akonni Biosystems
Becton Dickinson
Abbott
Hologic
Roche
Thermo Fischer Scientific
Hain Lifescience
Epistem
Creative Diagnostics
Cepheid
Siemens Healthineer

Please note: the online download version of this report is for a global site license.